Keywords: Almirall, Forest Labs, BioFocus, Aclidinium, Formoterol, Nine months 2011 financial results

Almirall starts Ph III COPD trial; collaborates with BioFocus; and posts sales and earnings downturn

Article | 16 November 2011

Print This

There was a batch of news from Spain’s largest drugmaker Almirall (ALM. MC), starting with the announcement that, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in